FDA NDC Directory · JSON-LD · Markdown

NAPROXEN SODIUM

NDC 68210-4096 · HUMAN OTC DRUG · TABLET, FILM COATED, EXTENDED RELEASE

Labeler / ManufacturerSPIRIT PHARMACEUTICALS,LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA091353
Dosage form / routeTABLET, FILM COATED, EXTENDED RELEASE · ORAL
Active ingredientsNAPROXEN SODIUM (220 mg/1)
Marketing started20200702
Package count1

External sources

Source: openFDA. Public-domain (CC0).